Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Other Non-Current Liabilities (2021 - 2025)

Medicinova (MNOV) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $17129.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $17129.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $17129.0, a N/A change, with the full-year FY2025 number at $17129.0, changed N/A from a year prior.
  • Other Non-Current Liabilities was $17129.0 for Q4 2025 at Medicinova, down from $74399.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $737716.0 in Q3 2021 to a low of $2211.0 in Q1 2021.
  • A 5-year average of $359103.6 and a median of $380922.5 in 2023 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: surged 28523.65% in 2022, then plummeted 70.84% in 2025.
  • Medicinova's Other Non-Current Liabilities stood at $694674.0 in 2021, then fell by 19.99% to $555840.0 in 2022, then dropped by 26.12% to $410660.0 in 2023, then crashed by 37.87% to $255150.0 in 2024, then plummeted by 93.29% to $17129.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Other Non-Current Liabilities are $17129.0 (Q4 2025), $74399.0 (Q3 2025), and $117038.0 (Q2 2025).